Announcement

Collapse

CHANGES AT MSWORLD - MSWORLD'S CLOSURE

We began with a mission and purpose to help others living with MS.

We were excited to get going!

And hit a few bumps along the way…

However, in all seriousness, we remain grateful for our amazing volunteers, members & all who have made MSWorld a valuable resource for all!

July 10, 2024, we celebrated the goodness of these past 28 years. With a heavy heart, we will be ending our services.

We need a financial miracle to keep going forward.

We thank all for your support.

MSWorld's website will close on October 16, 2024.

“I personally want to wish all of you the guidance to find this type of support, as so many do here. Also, my prayers and love extends beyond my understanding. It has been a pleasure to steward this journey.”

God Bless you, Kathleen

Kathleen Wilson
Founding President
❤️

we leave knowing that
we did our best and
stayed true to our mission and purpose.


Please visit our General Questions and Answers forum to read more.
See more
See less

Vumerity effective over 96 weeks in patients with RRMS

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Vumerity effective over 96 weeks in patients with RRMS

    Vumerity effective over 96 weeks in patients with relapsing-remitting MS

    Results from the EVOLVE-MS-1 study show Vumerity was effective and well-tolerated over 96 weeks in patients with relapsing-remitting MS compared with dimethyl fumarate, according to a presentation at ECTRIMS 2022.

    Full article: https://www.healio.com/news/neurolog...ngremitting-ms
Working...
X